Side-by-side comparison of AI visibility scores, market position, and capabilities
Maker of Nidra, the first FDA-authorized drug-free device for drug-refractory Restless Legs Syndrome. ~$24M ARR; acquired by ResMed for $340M (expected close June 2026).
Noctrix Health is a medical device company commercializing Nidra Therapy — the first and only FDA-authorized, drug-free treatment for drug-refractory Restless Legs Syndrome (RLS). The Nidra device uses Tonic Motor Activation (TOMAC) technology to deliver gentle electrical stimulation to the legs, reducing RLS symptoms without pharmaceutical side effects. The FDA granted De Novo authorization in 2023. In August 2025, Noctrix raised $33.5M in combined debt and equity to accelerate U.S. commercialization, reaching an annual revenue run rate of approximately $24M. ResMed signed an agreement in 2026 to acquire Noctrix Health for $340M, with the transaction expected to close around June 1, 2026 — Noctrix''s revenue will be reported within ResMed''s Americas Devices category post-close.
Epic holds over 42% of U.S. acute care hospital EHR market share and is embedding AI across 150+ clinical workflows for 2026, while facing antitrust scrutiny.
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale electronic health record systems and reports that more than 305 million patients have a record in Epic, covering the majority of U.S. academic medical centers and large health systems including Kaiser Permanente, Mayo Clinic, Johns Hopkins, and Cleveland Clinic. Epic commands approximately 42% of U.S. acute care hospitals and nearly 55% of acute care hospital beds, making it the undisputed market leader in enterprise EHR.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.